Perfusion CT as a Predictor of Treatment Response in Patients With Rectal Cancer

NCT01460641 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 21

Last updated 2018-09-07

No results posted yet for this study

Summary

A research study of rectal cancer perfusion (how blood flows to the rectum over time). We hope to learn whether perfusion characteristics of rectal masses may be predictive of response to treatment and whether rectal perfusion characteristics can be used to follow response to treatment.

Conditions

Sponsors & Collaborators

Principal Investigators

  • Aya Kamaya · Stanford University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-11-30
Primary Completion
2016-07-31
Completion
2018-07-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01460641 on ClinicalTrials.gov